Endo Pharmaceuticals Holdings Inc. 10,510,108 Shares Common Stock ($.01 par value) Underwriting AgreementUnderwriting Agreement • March 23rd, 2006 • Endo Pharmaceuticals Holdings Inc • Pharmaceutical preparations • New York
The persons named in Schedule I hereto (the “Selling Stockholders”), propose to sell to Bear, Stearns & Co. Inc. (the “Underwriter”), 10,510,108 shares of Common Stock, $.01 par value (“Common Stock”), of Endo Pharmaceuticals Holdings Inc., a corporation organized under the laws of Delaware (the “Company”) (said shares to be sold by the Selling Stockholders being hereinafter called the “Securities”). The Securities include shares of Common Stock (collectively, the “Stock Option Shares”) to be acquired by certain Selling Stockholders identified in Schedule I hereto (the “Stock Option Selling Stockholders”) upon exercise of currently outstanding options to purchase Common Stock granted under the stock option plans of the Company and Endo Pharma LLC.
